Published: June 2024
DOI: 10.1097/GCO.0000000000000942
Ho, Vu N-A.a; Ho, Tuong M.a; Vuong, Lan N.a,b; García-Velasco, Juanc,d,e
Authors information
aIVFMD and HOPE research center, My Duc Hospital
bDepartment of obstetrics and gynecology, University of Medicine and Pharmacy at Ho Chi Minh City, Viet Nam
cIVIRMA Global and IVI Madrid, Madrid
dIVI Foundation, IIS La Fe, Valencia
eRey Juan Carlos University, Madrid, Spain
Abstract
Purpose of review
In vitro maturation has become a significant component of modern assisted reproductive techniques. Published data have been supported for the safety and effectiveness of in vitro maturation treatment. In recent years, potential indications for in vitro maturation (IVM) have been a topic of interest and investigation.
Recent findings
Significant improvements in technique enhancement and data publication for evaluating the efficacy of IVM have been achieved. Recent studies have shown that IVM could offer several advantages over in vitro fertilization. Currently, there are growing indications for IVM beyond the commonly mentioned indication of infertile women with polycystic ovary syndrome. Additionally, some potential candidates might have significant advantages for IVM, such as women diagnosed with gonadotropin resistance ovary syndrome or those seeking fertility preservation. With a better understanding of IVM, from basic science to clinical practice, it can be applied safely, effectively, and affordably to a broader range of patients, making it a more accessible and patient-friendly option.
Summary
Despite the possibly acknowledged limitations, the potential of in vitro maturation cannot be denied. As this technique becomes increasingly accessible to patients and more continuous efforts are dedicated to advancing this technique, the impact of in vitro maturation is expected.